Literature DB >> 23052300

Pneumococci can persistently colonize adult patients with chronic respiratory disease.

A Domenech1, C Ardanuy, L Balsalobre, S Marti, L Calatayud, A G De la Campa, A B Brueggemann, J Liñares.   

Abstract

Streptococcus pneumoniae plays an important role in causing acute exacerbations in patients with chronic respiratory disease. However, few data are available regarding pneumococcal persistence in adult patients with chronic respiratory diseases. Fifty pneumococci recovered from sputum samples (1995 to 2010) from 13 adult patients with ≥ 3 episodes of acute exacerbation or pneumonia, with the same serotype and pulsed-field gel electrophoresis (PFGE) pattern, were studied. Multilocus sequence typing (MLST) loci, penicillin-binding protein (PBP) genes (pbp2x, pbp1a, pbp2b), and the quinolone-resistant determining regions (QRDRs) of parC, parE, and gyrA were PCR amplified and sequenced. The average time between the first and last episode was 582 days (standard deviation [SD], ± 362). All but two patients received multiple courses of β-lactam treatment, and all persistent strains were resistant to penicillin; however, the PBP sequences were stable over time apart from one variable nucleotide in pbp2x, observed among pneumococci isolated from three patients. In contrast, 7/11 patients treated with fluoroquinolones had fluoroquinolone-resistant pneumococci. In three patients, the initially fluoroquinolone-susceptible strain developed resistance after fluoroquinolone therapy, and in the remaining four patients, the persistent strain was fluoroquinolone resistant from the first episode. QRDR changes involved in fluoroquinolone resistance were frequently observed in persistent strains after fluoroquinolone treatment; however, the PBP sequences and MLST genotypes of these strains were stable over time.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23052300      PMCID: PMC3502946          DOI: 10.1128/JCM.02056-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.

Authors:  Ross Davidson; Rodrigo Cavalcanti; James L Brunton; Darrin J Bast; Joyce C S de Azavedo; Pamela Kibsey; Christine Fleming; Donald E Low
Journal:  N Engl J Med       Date:  2002-03-07       Impact factor: 91.245

2.  Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990).

Authors:  J Liñares; R Pallares; T Alonso; J L Perez; J Ayats; F Gudiol; P F Viladrich; R Martin
Journal:  Clin Infect Dis       Date:  1992-07       Impact factor: 9.079

Review 3.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

4.  Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae.

Authors:  X S Pan; J Ambler; S Mehtar; L M Fisher
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

5.  Nonoptimal DNA topoisomerases allow maintenance of supercoiling levels and improve fitness of Streptococcus pneumoniae.

Authors:  Luz Balsalobre; María José Ferrándiz; Gabriela de Alba; Adela G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  2010-12-20       Impact factor: 5.191

6.  Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization.

Authors:  B Rosón; J Carratalà; R Verdaguer; J Dorca; F Manresa; F Gudiol
Journal:  Clin Infect Dis       Date:  2000-10-12       Impact factor: 9.079

7.  Requirement for capsule in colonization by Streptococcus pneumoniae.

Authors:  A D Magee; J Yother
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

8.  A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease.

Authors:  Mark C Enright; Brian G Spratt
Journal:  Microbiology (Reading)       Date:  1998-11       Impact factor: 2.777

9.  New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.

Authors:  Sanjay Sethi; Nancy Evans; Brydon J B Grant; Timothy F Murphy
Journal:  N Engl J Med       Date:  2002-08-15       Impact factor: 91.245

10.  Fluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae clones, Spain.

Authors:  Adela G de la Campa; Luz Balsalobre; Carmen Ardanuy; Asunción Fenoll; Emilio Pérez-Trallero; Josefina Liñares
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883

View more
  7 in total

1.  Development and characterization of a long-term murine model of Streptococcus pneumoniae infection of the lower airways.

Authors:  Louise Haste; Kathryn Hulland; Sarah Bolton; Hasan Yesilkaya; Kenneth McKechnie; Peter W Andrew
Journal:  Infect Immun       Date:  2014-05-27       Impact factor: 3.441

2.  Induction of prophages by fluoroquinolones in Streptococcus pneumoniae: implications for emergence of resistance in genetically-related clones.

Authors:  Elena López; Arnau Domenech; María-José Ferrándiz; Maria João Frias; Carmen Ardanuy; Mario Ramirez; Ernesto García; Josefina Liñares; Adela G de la Campa
Journal:  PLoS One       Date:  2014-04-09       Impact factor: 3.240

3.  Overview of pneumococcal serotypes and genotypes causing diseases in patients with chronic obstructive pulmonary disease in a Spanish hospital between 2013 and 2016.

Authors:  Hisashi Shoji; Daniel A Vázquez-Sánchez; Aida Gonzalez-Diaz; Meritxell Cubero; Fe Tubau; Salud Santos; Dolores García-Somoza; Josefina Liñares; José Yuste; Sara Martí; Carmen Ardanuy
Journal:  Infect Drug Resist       Date:  2018-09-04       Impact factor: 4.003

4.  Face mask sampling reveals antimicrobial resistance genes in exhaled aerosols from patients with chronic obstructive pulmonary disease and healthy volunteers.

Authors:  Matthew Kennedy; Mohammadali Y Ramsheh; Caroline M L Williams; Joss Auty; Koirobi Haldar; Mohamad Abdulwhhab; Christopher E Brightling; Michael R Barer
Journal:  BMJ Open Respir Res       Date:  2018-09-23

5.  Some pneumococcal serotypes are more frequently associated with relapses of acute exacerbations in COPD patients.

Authors:  Arnau Domenech; Carmen Ardanuy; Roman Pallares; Immaculada Grau; Salud Santos; Adela G De la Campa; Josefina Liñares
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

6.  Evolution and genetic diversity of the Spain23F-ST81 clone causing adult invasive pneumococcal disease in Barcelona (1990-2012).

Authors:  A Domenech; C Ardanuy; I Grau; L Calatayud; R Pallares; A Fenoll; A B Brueggemann; J Liñares
Journal:  J Antimicrob Chemother       Date:  2013-12-08       Impact factor: 5.790

Review 7.  Role of Inflammatory Risk Factors in the Pathogenesis of Streptococcus pneumoniae.

Authors:  Ifrah Sohail; Sumit Ghosh; Santhosh Mukundan; Susan Zelewski; M Nadeem Khan
Journal:  Front Immunol       Date:  2018-10-02       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.